FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2416924784> ?p ?o ?g. }

• W2416924784 endingPage "2641" @default.
• W2416924784 startingPage "2641" @default.
• W2416924784 abstract "Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis Seda Rençber,1 Sinem Yaprak Karavana,1 Fethiye Ferda Yilmaz,2 Bayri Eraç,2 Merve Nenni,3 Seda Özbal,4 Çetin Pekçetin,4 Hande Gurer-Orhan,3 Mine Hosgör Limoncu,2 Pelin Güneri,5 Gökhan Ertan11Faculty of Pharmacy, Department of Pharmaceutical Technology, 2Department of Pharmaceutical Microbiology, 3Department of Pharmaceutical Toxicology, Ege University, Bornova, Turkey; 4Department of Histology and Embryology, School of Medicine, Dokuz Eylul University, Inciralti, Turkey; 5Faculty of Dentistry, Department of Oral Diagnosis and Radiology, Ege University, Bornova, TurkeyAbstract: This study aimed to develop a suitable buccal mucoadhesive nanoparticle (NP) formulation containing fluconazole for the local treatment of oral candidiasis. The suitability of the prepared formulations was assessed by means of particle size (PS), polydispersity index, and zeta potential measurements, morphology analysis, mucoadhesion studies, drug entrapment efficiency (EE), in vitro drug release, and stability studies. Based on the optimum NP formulation, ex vivo drug diffusion and in vitro cytotoxicity studies were performed. Besides, evaluation of the antifungal effect of the optimum formulation was evaluated using agar diffusion method, fungicidal activity-related in vitro release study, and time-dependent fungicidal activity. The effect of the optimum NP formulation on the healing of oral candidiasis was investigated in an animal model, which was employed for the first time in this study. The zeta potential, mucoadhesion, and in vitro drug release studies of various NP formulations revealed that chitosan-coated NP formulation containing EUDRAGIT® RS 2.5% had superior properties than other formulations. Concerning the stability study of the selected formulation, the formulation was found to be stable for 6 months. During the ex vivo drug diffusion study, no drug was found in receptor phase, and this is an indication of local effect. The in vitro antifungal activity studies showed the in vitro efficacy of the NP against Candida albicans for an extended period. Also, the formulation had no cytotoxic effect at the tested concentration. For the in vivo experiments, infected rabbits were successfully treated with local administration of the optimum NP formulation once a day. This study has shown that the mucoadhesive NP formulation containing fluconazole is a promising candidate with once-a-day application for the local treatment of oral candidiasis.Keywords: mucoadhesive nanoparticle, buccal application, oral candidiasis, fluconazole, chitosan" @default.
• W2416924784 created "2016-06-24" @default.
• W2416924784 creator A5009719341 @default.
• W2416924784 creator A5010046340 @default.
• W2416924784 creator A5014735460 @default.
• W2416924784 creator A5016370416 @default.
• W2416924784 creator A5022969019 @default.
• W2416924784 creator A5033575583 @default.
• W2416924784 creator A5046696950 @default.
• W2416924784 creator A5050480972 @default.
• W2416924784 creator A5080824711 @default.
• W2416924784 creator A5087973494 @default.
• W2416924784 creator A5090957138 @default.
• W2416924784 date "2016-06-01" @default.
• W2416924784 modified "2023-10-14" @default.
• W2416924784 title "Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis" @default.
• W2416924784 cites W1520722558 @default.
• W2416924784 cites W1622931668 @default.
• W2416924784 cites W1964217657 @default.
• W2416924784 cites W1977717521 @default.
• W2416924784 cites W1981460456 @default.
• W2416924784 cites W2004332682 @default.
• W2416924784 cites W2010929111 @default.
• W2416924784 cites W2016327987 @default.
• W2416924784 cites W2020087566 @default.
• W2416924784 cites W2025409677 @default.
• W2416924784 cites W2028128869 @default.
• W2416924784 cites W2041657994 @default.
• W2416924784 cites W2045584709 @default.
• W2416924784 cites W2052080571 @default.
• W2416924784 cites W2056391196 @default.
• W2416924784 cites W2057026918 @default.
• W2416924784 cites W2059810165 @default.
• W2416924784 cites W2067872850 @default.
• W2416924784 cites W2070326805 @default.
• W2416924784 cites W2071961359 @default.
• W2416924784 cites W2074967251 @default.
• W2416924784 cites W2092320384 @default.
• W2416924784 cites W2094467276 @default.
• W2416924784 cites W2104229644 @default.
• W2416924784 cites W2112515081 @default.
• W2416924784 cites W2123286415 @default.
• W2416924784 cites W2131021124 @default.
• W2416924784 cites W2135215701 @default.
• W2416924784 cites W2147901837 @default.
• W2416924784 cites W2153439840 @default.
• W2416924784 cites W2220518688 @default.
• W2416924784 doi "https://doi.org/10.2147/ijn.s103762" @default.
• W2416924784 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4912316" @default.
• W2416924784 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27358561" @default.
• W2416924784 hasPublicationYear "2016" @default.
• W2416924784 type Work @default.
• W2416924784 sameAs 2416924784 @default.
• W2416924784 citedByCount "70" @default.
• W2416924784 countsByYear W24169247842017 @default.
• W2416924784 countsByYear W24169247842018 @default.
• W2416924784 countsByYear W24169247842019 @default.
• W2416924784 countsByYear W24169247842020 @default.
• W2416924784 countsByYear W24169247842021 @default.
• W2416924784 countsByYear W24169247842022 @default.
• W2416924784 countsByYear W24169247842023 @default.
• W2416924784 crossrefType "journal-article" @default.
• W2416924784 hasAuthorship W2416924784A5009719341 @default.
• W2416924784 hasAuthorship W2416924784A5010046340 @default.
• W2416924784 hasAuthorship W2416924784A5014735460 @default.
• W2416924784 hasAuthorship W2416924784A5016370416 @default.
• W2416924784 hasAuthorship W2416924784A5022969019 @default.
• W2416924784 hasAuthorship W2416924784A5033575583 @default.
• W2416924784 hasAuthorship W2416924784A5046696950 @default.
• W2416924784 hasAuthorship W2416924784A5050480972 @default.
• W2416924784 hasAuthorship W2416924784A5080824711 @default.
• W2416924784 hasAuthorship W2416924784A5087973494 @default.
• W2416924784 hasAuthorship W2416924784A5090957138 @default.
• W2416924784 hasBestOaLocation W24169247841 @default.
• W2416924784 hasConcept C150903083 @default.
• W2416924784 hasConcept C155672457 @default.
• W2416924784 hasConcept C16005928 @default.
• W2416924784 hasConcept C171250308 @default.
• W2416924784 hasConcept C178855305 @default.
• W2416924784 hasConcept C185592680 @default.
• W2416924784 hasConcept C192562407 @default.
• W2416924784 hasConcept C195735259 @default.
• W2416924784 hasConcept C207001950 @default.
• W2416924784 hasConcept C26291073 @default.
• W2416924784 hasConcept C2776634624 @default.
• W2416924784 hasConcept C2779548794 @default.
• W2416924784 hasConcept C2779820397 @default.
• W2416924784 hasConcept C2780020223 @default.
• W2416924784 hasConcept C2780651595 @default.
• W2416924784 hasConcept C71924100 @default.
• W2416924784 hasConcept C86181022 @default.
• W2416924784 hasConcept C86803240 @default.
• W2416924784 hasConcept C98274493 @default.
• W2416924784 hasConceptScore W2416924784C150903083 @default.
• W2416924784 hasConceptScore W2416924784C155672457 @default.
• W2416924784 hasConceptScore W2416924784C16005928 @default.
• W2416924784 hasConceptScore W2416924784C171250308 @default.
• W2416924784 hasConceptScore W2416924784C178855305 @default.

• next